Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qinglong Jin

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Hepatocellular Carcinoma|October 30, 2020
Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese PatientsMiaoxia Liu, Ruihong Wu, Xu Liu, et al.
Hepatology (Baltimore, Md.)|December 3, 2011
Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosisQinglong Jin, Yuki Moritoki, Ana Lleo, et al.
Alimentary Pharmacology & Therapeutics|September 29, 2021
Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis BZhihong Liu, Qinglong Jin, Yuexin Zhang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 30, 2020
Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeksXiaomei Wang, Zhongfeng Wang, Xiumei Chi, et al.
The Lancet. Gastroenterology & Hepatology|October 31, 2025
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trialGideon M Hirschfield, Christopher L Bowlus, David E J Jones, et al.
Journal of Clinical and Translational Hepatology|March 27, 2023
96-Week Treatment of Tenofovir Amibufenamide and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B PatientsZhihong Liu, Qinglong Jin, Yuexin Zhang, et al.
Hepatology International|July 23, 2025
A randomized, phase Ib trial of recombinant human serum albumin in cirrhotic patients with ascitesXinrui Wang, Wanyu Li, Fei Kong, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Hepatocellular Carcinoma|October 30, 2020
Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese PatientsMiaoxia Liu, Ruihong Wu, Xu Liu, et al.
Hepatology (Baltimore, Md.)|December 3, 2011
Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosisQinglong Jin, Yuki Moritoki, Ana Lleo, et al.
Alimentary Pharmacology & Therapeutics|September 29, 2021
Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis BZhihong Liu, Qinglong Jin, Yuexin Zhang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 30, 2020
Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeksXiaomei Wang, Zhongfeng Wang, Xiumei Chi, et al.
The Lancet. Gastroenterology & Hepatology|October 31, 2025
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trialGideon M Hirschfield, Christopher L Bowlus, David E J Jones, et al.
Journal of Clinical and Translational Hepatology|March 27, 2023
96-Week Treatment of Tenofovir Amibufenamide and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B PatientsZhihong Liu, Qinglong Jin, Yuexin Zhang, et al.
Hepatology International|July 23, 2025
A randomized, phase Ib trial of recombinant human serum albumin in cirrhotic patients with ascitesXinrui Wang, Wanyu Li, Fei Kong, et al.
Pageof 5